Drug resistance in non-small cell lung Cancer (NSCLC): Impact of genetic and non-genetic alterations on therapeutic regimen and responsiveness
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Pharmacology
Reference43 articles.
1. Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumors;Akbay;Cancer Discovery,2013
2. Association of PD-L1 overexpression with activating EGFR mutations in surgically resected nonsmall-cell lung cancer;Azuma;Annals of Oncology,2014
3. Targeted therapy for non-small cell lung cancer: Current standards and the promise of the future;Chan;Transl Lung Cancer Res.,2015
4. The EGFR T790M mutation is acquired through AICDA-mediated deamination of 5-methylcytosine following TKI treatment in lung cancer;El Kadi;Cancer Research,2018
5. Emerging paradigms in the development of resistance to tyrosine kinase inhibitors in lung cancer;Gainor;Journal of Clinical Oncology,2013
Cited by 43 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. IGFBP2/ITGA5 promotes gefitinib resistance via activating STAT3/CXCL1 axis in non-small cell lung cancer;Cell Death & Disease;2024-06-25
2. First-line penpulimab combined with paclitaxel and carboplatin for metastatic squamous non-small-cell lung cancer in China (AK105-302): a multicentre, randomised, double-blind, placebo-controlled phase 3 clinical trial;The Lancet Respiratory Medicine;2024-05
3. Frequency and functional characterization of fusion genes in squamous cell carcinoma of the lung;Gene;2024-02
4. LINC00968 and LINC00511 Regulate Gefitinib-Induced Proliferation Inhibition and Apoptosis and Drug Resistance-Related Genes in Non-Small-Cell Lung Cancer;J BIOL REG HOMEOS AG;2023
5. CRISPR/Cas9-mediated silencing of CD44: unveiling the role of hyaluronic acid-mediated interactions in cancer drug resistance;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-11-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3